Prognostic significance of lymph node variables in squamous cell carcinoma of the vulva
- PMID: 7923005
- DOI: 10.1002/1097-0142(19941101)74:9<2491::aid-cncr2820740916>3.0.co;2-5
Prognostic significance of lymph node variables in squamous cell carcinoma of the vulva
Abstract
Background: In patients with squamous cell carcinoma of the vulva, lymph nodal, surgicopathologic variables have been studied rarely, although lymph node status is by far the most important prognostic factor. This study was designed to investigate surgicopathologic variables of lymph node metastases to evaluate their prognostic significance.
Methods: In 75 patients with inguinal and/or pelvic lymph node metastases from squamous cell carcinoma of the vulva, the following parameters were studied: size and location of the tumor, depth of invasion, grade, lymph-vascular space involvement (LVSI), local immune reaction, presence and degree of dystrophic changes in the surrounding skin, FIGO stage, number of positive lymph nodes, greatest dimension of the metastasis within the lymph node, percentage of lymph node replacement, number of lymph nodes with replacement greater than 50%, number of lymph nodes replaced completely by tumor, extracapsular spread, and active immunologic response within the lymph node.
Results: Among the variables related to the primary carcinomas, only size of the tumor and LVSI were correlated with survival (P < 0.003 and P < 0.02, respectively). On the contrary, all pathologic variables regarding the lymph nodes significantly influenced survival by univariate analysis. On multivariate analysis, extracapsular spread was the most significant independent prognostic factor (P < 0.0004), followed by FIGO stage (P < 0.03). For patients with only one positive lymph node, the most important prognostic factor was the greatest dimension of the metastasis within the lymph node (P < 0.01).
Conclusions: These data, if confirmed in larger series, can contribute to a more accurate identification of low and high risk patients and, therefore, to a more appropriate employment of adjuvant therapies.
Comment in
-
Lymph node findings and outcome in squamous cell carcinoma of the vulva.Cancer. 1994 Nov 1;74(9):2399-402. doi: 10.1002/1097-0142(19941101)74:9<2399::aid-cncr2820740903>3.0.co;2-v. Cancer. 1994. PMID: 7922992 No abstract available.
Similar articles
-
Extracapsular growth of lymph node metastases in squamous cell carcinoma of the vulva. The impact on recurrence and survival.Cancer. 1995 Jun 15;75(12):2885-90. doi: 10.1002/1097-0142(19950615)75:12<2885::aid-cncr2820751215>3.0.co;2-3. Cancer. 1995. PMID: 7773938
-
Clinical and pathological prognostic factors in squamous cell carcinoma of the vulva.Gynecol Oncol. 2006 Aug;102(2):333-7. doi: 10.1016/j.ygyno.2005.12.027. Epub 2006 Feb 7. Gynecol Oncol. 2006. PMID: 16466657
-
Prognostic variables in the treatment of squamous cell carcinoma of the vulva.Gynecol Oncol. 1986 Jul;24(3):343-58. doi: 10.1016/0090-8258(86)90312-4. Gynecol Oncol. 1986. PMID: 3721307
-
Surgical management of invasive carcinoma of the vulva. A retrospective analysis and review.Eur J Gynaecol Oncol. 2011;32(5):505-8. Eur J Gynaecol Oncol. 2011. PMID: 22053662 Review.
-
FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.Semin Surg Oncol. 1994 Jan-Feb;10(1):31-46. doi: 10.1002/ssu.2980100107. Semin Surg Oncol. 1994. PMID: 8115784 Review.
Cited by
-
Preoperative CA125 and fibrinogen in patients with endometrial cancer: a risk model for predicting lymphovascular space invasion.J Gynecol Oncol. 2017 Mar;28(2):e11. doi: 10.3802/jgo.2017.28.e11. Epub 2016 Oct 27. J Gynecol Oncol. 2017. PMID: 27894164 Free PMC article.
-
CXCR4/ACKR3/CXCL12 axis in the lymphatic metastasis of vulvar squamous cell carcinoma.J Clin Pathol. 2022 May;75(5):324-332. doi: 10.1136/jclinpath-2020-206917. Epub 2021 Mar 10. J Clin Pathol. 2022. PMID: 33692092 Free PMC article.
-
Vulvar carcinoma.Curr Treat Options Oncol. 2000 Jun;1(2):177-90. doi: 10.1007/s11864-000-0063-4. Curr Treat Options Oncol. 2000. PMID: 12057056 Review.
-
[Changes in the TNM classification of gynecological tumors].Pathologe. 2010 Sep;31(5):367-73. doi: 10.1007/s00292-010-1308-z. Pathologe. 2010. PMID: 20844876 German.
-
Management of patients with vulvar cancer: a perspective review according to tumour stage.Ther Adv Med Oncol. 2013 May;5(3):183-92. doi: 10.1177/1758834012471699. Ther Adv Med Oncol. 2013. PMID: 23634196 Free PMC article.
MeSH terms
LinkOut - more resources
Medical